Matches in Nanopublications for { ?s ?p "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP197353.RAbrzCIZCQI0I7apHMO57LODu2e1ujcyAj0OZJiyKB0u4130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197353.RAbrzCIZCQI0I7apHMO57LODu2e1ujcyAj0OZJiyKB0u4130_provenance.
- assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP197466.RAlWiuSEsC2F7VeqHPBwXSPxBVGQoKMoFHML0FmVZMOfQ130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197466.RAlWiuSEsC2F7VeqHPBwXSPxBVGQoKMoFHML0FmVZMOfQ130_provenance.
- assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP197469.RAEGrW2K4iVsDSHxgYVgAYCrZFoTUyLzl70RQoyVwAz9U130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197469.RAEGrW2K4iVsDSHxgYVgAYCrZFoTUyLzl70RQoyVwAz9U130_provenance.